Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease
- PMID: 10051466
- DOI: 10.1002/hep.510290347
Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease
Abstract
We characterized 70 consecutive patients with cryptogenic cirrhosis to assess major risks for liver disease. Each patient was reevaluated for past alcohol exposure, scored by the International Autoimmune Hepatitis (IAH) score and assessed for viral hepatitis risks and risks for nonalcoholic steatohepatitis (NASH). The results were compared with 50 consecutive NASH patients, 39 nonalcoholic patients age 50 and over with cirrhosis from hepatitis C, and 33 consecutive patients with cirrhosis caused by primary biliary cirrhosis (PBC). Among the cryptogenic group, 49 (70%) were female, and the mean age was 63 +/- 11 years. Although ascites and variceal bleeding were common, almost one half lacked major signs of complicated portal hypertension. A history of Type 2 diabetes mellitus and/or obesity was present in 51 (73%). Nineteen (27%) patients had a history of blood transfusions antedating the diagnosis of cirrhosis. No clinical or histological features distinguished this group from the other patients, and 14 (74%) of these had a history of obesity and/or diabetes. Nineteen of the remaining nontransfused patients had indeterminant IAH scores but were histologically and biochemically indistinguishable from the others. Twelve of these (63%) also had a history of obesity and/or diabetes. Both diabetes and obesity were significantly more common in the cryptogenic cirrhotic patients compared with the cirrhotic patients with PBC or hepatitis C. In contrast, the prevalence of obesity and diabetes was similar to the NASH patients who were, on average, a decade younger. Although there is some diversity that indicates more than one cause, our findings suggest that NASH plays an under-recognized role in many patients with cryptogenic cirrhosis, most of whom are older, type 2 diabetic and obese females.
Similar articles
-
Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study.Hepatology. 2000 Oct;32(4 Pt 1):689-92. doi: 10.1053/jhep.2000.17894. Hepatology. 2000. PMID: 11003611
-
Clinical characteristics of patients with cryptogenic liver cirrhosis in Okinawa, Japan.Hepatogastroenterology. 2003 Nov-Dec;50(54):2005-8. Hepatogastroenterology. 2003. PMID: 14696453
-
Prevalence of obesity, diabetes mellitus and hyperlipidaemia in patients with cryptogenic liver cirrhosis.Trop Gastroenterol. 2004 Jan-Mar;25(1):15-7. Trop Gastroenterol. 2004. PMID: 15303464
-
[Nonalcoholic steatohepatitis--current treatment options].Przegl Lek. 2006;63(2):91-4. Przegl Lek. 2006. PMID: 16967716 Review. Polish.
-
Non-alcoholic steatohepatitis in children.Pediatr Transplant. 2004 Dec;8(6):613-8. doi: 10.1111/j.1399-3046.2004.00241.x. Pediatr Transplant. 2004. PMID: 15598336 Review.
Cited by
-
Unexplained findings of kayser-fleischer-like rings in a patient with cryptogenic cirrhosis.Case Rep Gastrointest Med. 2012;2012:438525. doi: 10.1155/2012/438525. Epub 2012 Mar 15. Case Rep Gastrointest Med. 2012. PMID: 22606437 Free PMC article.
-
Non-alcoholic Fatty Liver Disease: East Versus West.J Clin Exp Hepatol. 2012 Jun;2(2):122-34. doi: 10.1016/S0973-6883(12)60101-7. Epub 2012 Jul 21. J Clin Exp Hepatol. 2012. PMID: 25755421 Free PMC article.
-
Development of poly(vinyl acetate-methylacrylic acid)/chitosan/Fe3O4 nanoparticles for the diagnosis of non-alcoholic steatohepatitis with magnetic resonance imaging.J Mater Sci Mater Med. 2012 Dec;23(12):3075-82. doi: 10.1007/s10856-012-4763-7. Epub 2012 Sep 14. J Mater Sci Mater Med. 2012. PMID: 22976475
-
Hepatocellular Carcinoma Screening and Nonalcoholic Fatty Liver Disease: How is it Different?J Clin Exp Hepatol. 2020 Sep-Oct;10(5):518-524. doi: 10.1016/j.jceh.2020.04.004. Epub 2020 Apr 18. J Clin Exp Hepatol. 2020. PMID: 33029058 Free PMC article. Review.
-
Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease.World J Gastroenterol. 2007 Jul 14;13(26):3540-53. doi: 10.3748/wjg.v13.i26.3540. World J Gastroenterol. 2007. PMID: 17659704 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous